Terms: = Ovarian cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659 AND Treatment
2 results:
1. PG545 sensitizes ovarian cancer cells to PARP inhibitors through modulation of RAD51-dek interaction.
Ray U; Thirusangu P; Jin L; Xiao Y; Pathoulas CL; Staub J; Erskine CL; Dredge K; Hammond E; Block MS; Kaufmann SH; Bakkum-Gamez JN; Shridhar V
Oncogene; 2023 Sep; 42(37):2725-2736. PubMed ID: 37550562
[TBL] [Abstract] [Full Text] [Related]
2. The dek Oncoprotein Functions in ovarian cancer Growth and Survival.
Hacker KE; Bolland DE; Tan L; Saha AK; Niknafs YS; Markovitz DM; McLean K
Neoplasia; 2018 Dec; 20(12):1209-1218. PubMed ID: 30412857
[TBL] [Abstract] [Full Text] [Related]
